The company said that the full data from studies on Covaxin's neutralization of variants are already published at "bioRxiv", Clinical Infectious Diseases, and Journal of Travel Medicine.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3grTiAe
via IFTTT
0 comments:
Post a Comment